Uso de heparina em pacientes com COVID-19 grave: Quais as evidências?

Autor: Marinho, Vitória Ribeiro Dantas, Villarim, Camila Vilar Oliveira, Silva, Laura Cristina Costa e, Silva, André Luiz Costa e, Araújo-Neto, Irami, Caldas, Diego Maia Diogenes Rabelo, Rêgo, Amália Cinthia Meneses, Araújo-Filho, Irami

Publikováno v: Research, Society and Development; Vol. 10 No. 6; e28910615820
Research, Society and Development; Vol. 10 Núm. 6; e28910615820
Research, Society and Development; v. 10 n. 6; e28910615820
Research, Society and Development
Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI

The rapid spread of coronavirus disease (COVID-19) worldwide urges the need for studies on the illness and its management. The COVID-19 infection leads to hypercoagulation due to inflammatory cytokine release and D-dimer increase in critically ill pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::99b390009860bfb4b87718ef24c20676
https://rsdjournal.org/index.php/rsd/article/view/15820